Patents by Inventor Lisa Marie Havran

Lisa Marie Havran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperazine-piperidine antagonists and agonists of the 5-HT receptor
    Patent number: 7671056
    Abstract: The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction. The invention relates to compounds and pharmaceutically acceptable salts of formula (I?): wherein R1-R16, Ra, Rb, and n are set forth in the specification. The invention also relates to pharmaceutical compositions comprising compounds and pharmaceutically acceptable salts of formula (I?).
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: March 2, 2010
    Assignee: Wyeth LLC
    Inventors: Magda Asselin, George Theodore Grosu, Annmarie Louise Sabb, Wayne Everett Childers, Lisa Marie Havran, Zhongqi Shen, James Jacob Bicksler, Dan Chaekoo Chong
  • SUBSTITUTED ARYL OXIMES
    Publication number: 20080293790
    Abstract: The present invention relates to substituted aryl oximes and methods of using them.
    Type: Application
    Filed: July 28, 2008
    Publication date: November 27, 2008
    Applicant: Wyeth
    Inventors: Lisa Marie Havran, John Anthony Butera, Hassan Mahmoud Elokdah, Douglas John Jenkins, Eric Gould Gundersen
  • Substituted aryloximes
    Patent number: 7420083
    Abstract: The present invention relates to substituted aryl oximes and methods of using them.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: September 2, 2008
    Assignee: Wyeth
    Inventors: Lisa Marie Havran, John Anthony Butera, Hassan Mahmoud Elokdah, Douglas John Jenkins, Eric Gould Gundersen
  • Substituted indole oximes
    Patent number: 7342039
    Abstract: The present invention relates to substituted indole oximes and methods of using them.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: March 11, 2008
    Assignee: Wyeth
    Inventors: Lisa Marie Havran, John Anthony Butera, Hassan Mahmoud Elokdah, Douglas John Jenkins, Eric Gould Gundersen
  • Pyrimidoindolones and methods for using same
    Patent number: 7256198
    Abstract: Novel pyrimidoindolone compounds are disclosed. Methods of using the pyrimidoindolone compounds and compositions containing the compounds in the treatment and/or prevention of disease and other conditions related to inflammation, neurodegeneration, osteoarthritis and apoptosis are also disclosed.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: August 14, 2007
    Assignee: Wyeth
    Inventors: Paul Jeffrey Dollings, Arlene Joan Dietrich, Lisa Marie Havran, Chae-Koo Dan Chong, Donna Mary Huryn, Albert Jean Robichaud, Boyd Lynn Harrison, Wayne Everett Childers, Alexander A. Greenfield, James Jacob Bicksler, Vasilios Marathias
  • 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
    Patent number: 7008636
    Abstract: This invention provides compounds of Formula I having the structure or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: March 7, 2006
    Assignee: Wyeth
    Inventors: John A. Butera, Craig E. Caufield, Russell F. Graceffa, Alexander Greenfield, Eric G. Gundersen, Lisa Marie Havran, Alan H. Katz, Joseph R. Lennox, Scott C. Mayer, Robert E. McDevitt
  • 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
    Publication number: 20040214869
    Abstract: This invention provides compounds of Formula I having the structure 1
    Type: Application
    Filed: May 11, 2004
    Publication date: October 28, 2004
    Applicant: Wyeth
    Inventors: John A. Butera, Craig E. Caufield, Russell F. Graceffa, Alexander Greenfield, Eric G. Gundersen, Lisa Marie Havran, Alan H. Katz, Joseph R. Lennox, Scott C. Mayer, Robert E. McDevitt
  • 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
    Patent number: 6765021
    Abstract: This invention provides compounds of formula I having the structure wherein: B, D, C, and R1 as defined herein.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: July 20, 2004
    Assignee: Wyeth
    Inventors: John A. Butera, Craig E. Caufield, Russell F. Graceffa, Alexander Greenfield, Eric G. Gundersen, Lisa Marie Havran, Alan H. Katz, Joseph R. Lennox, Scott C. Mayer, Robert E. McDevitt
  • 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
    Patent number: 6451827
    Abstract: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: September 17, 2002
    Assignee: Wyeth
    Inventors: John A. Butera, Craig E. Caufield, Russell F. Graceffa, Alexander Greenfield, Eric G. Gundersen, Lisa Marie Havran, Alan H. Katz, Joseph R. Lennox, Scott C. Mayer, Robert E. McDevitt
  • 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
    Patent number: 6214877
    Abstract: This invention provides compounds of Formula I having the structure wherein: B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
    Type: Grant
    Filed: May 10, 1999
    Date of Patent: April 10, 2001
    Inventors: John A. Butera, Craig E. Caufield, Russell F. Graceffa, Alexander Greenfield, Eric G. Gundersen, Lisa Marie Havran, Alan H. Katz, Joseph R. Lennox, Scott C. Mayer, Robert E. McDevitt